Related Articles
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs
Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients
Metabolic comorbidities of psoriasis (Review)
Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis
Protective effect of Salvia miltiorrhiza Bunge on 5-fluorouracil-induced oral mucositis